George Coukos

Active 1992–2025

226
Papers
60,702
Citations
113
h-index
216
i10-index

Citations

Citations per year for George Coukos1995: 2 citations1996: 5 citations1999: 6 citations2000: 5 citations2001: 6 citations2002: 15 citations2003: 39 citations2004: 98 citations2005: 211 citations2006: 279 citations2007: 309 citations2008: 384 citations2009: 446 citations2010: 489 citations2011: 490 citations2012: 558 citations2013: 632 citations2014: 543 citations2015: 660 citations2016: 685 citations2017: 790 citations2018: 749 citations2019: 2,216 citations2020: 2,899 citations2021: 3,154 citations2022: 2,745 citations2023: 2,344 citations2024: 3,244 citations2025: 1,860 citations2026: 57 citations1997–1998: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 7,969 citing papers, 25.9% of this breakdownChina: 5,937 citing papers, 19.3% of this breakdownGermany: 1,489 citing papers, 4.8% of this breakdownUnited Kingdom: 1,423 citing papers, 4.6% of this breakdownItaly: 1,283 citing papers, 4.2% of this breakdownFrance: 1,069 citing papers, 3.5% of this breakdownSwitzerland: 879 citing papers, 2.8% of this breakdownJapan: 855 citing papers, 2.8% of this breakdownCanada: 802 citing papers, 2.6% of this breakdownNetherlands: 725 citing papers, 2.3% of this breakdownAustralia: 716 citing papers, 2.3% of this breakdownSpain: 657 citing papers, 2.1% of this breakdown
0%25.9%Other 22.8%

Fields

  • Medicine42.7%
  • Biochemistry, Genetics and Molecular Biology27.5%
  • Immunology and Microbiology22.2%
  • Engineering3.8%
  • Neuroscience1%
  • Materials Science0.7%
  • Other2.1%

Topics

  • Cancer Immunotherapy and Biomarkers10%
  • Immunotherapy and Immune Responses8.3%
  • Immune Cell Function and Interaction5.9%
  • CAR-T cell therapy research5%
  • Immune cells in cancer3.8%
  • MicroRNA in disease regulation2.4%
  • Other64.6%

Coauthors

All papers

Open in search
  1. Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance

    Authors: , , , , , , , , , , , , , , , , - Nature Reviews Clinical Oncology 2019 cited by 2,242

  2. Cancer immunotherapy comes of age

    Authors: , , - Nature 2011 cited by 3,905

  3. Disturbed mitochondrial dynamics in CD8+ TILs reinforce T cell exhaustion

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Immunology 2020 cited by 569

  4. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2019 cited by 910

  5. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sherene Loi, Michael T. Lotze, Gwenola Manic, Taha Merghoub, Alan Melcher, Karen Mossman, Felipe Prósper, Øystein Rekdal, María Rescigno, Chiara Riganti, Antonella Sistigu, Mark J. Smyth, Radek Špíšek, John Stagg, Bryan E. Strauss, Daolin Tang, Kazuki Tatsuno, Stefaan Van Gool, Peter Vandenabeele, Takahiro Yamazaki, Dmitriy Zamarin, Laurence Zitvogel, Alessandra Cesano, Francesco M. Marincola - Journal for ImmunoTherapy of Cancer 2020 cited by 1,061

  6. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2004 cited by 5,059

  7. Interpretation of T cell states from single-cell transcriptomics data using reference atlases

    Authors: , , , , , - Nature Communications 2021 cited by 581

  8. Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells

    Authors: , , , , , , , , , , - Nature 2011 cited by 1,372

  9. Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer

    Authors: , , , , , , , , , , , - New England Journal of Medicine 2003 cited by 3,410

  10. Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Beata Berent-Maoz, Beatriz M. Carreno, Bin Song, Bjoern Peters, Bo Li, Brandon W. Higgs, Brian J. Stevenson, Christian Iseli, Christopher A. Miller, Christopher Morehouse, Cornelis J.M. Melief, Cristina Puig-Saus, Daphne M. van Beek, David Balli, David Gfeller, David Haussler, Dirk Jäger, Eduardo Cortes, Ekaterina Esaulova, Elham Sherafat, Francisco Arcila, Gábor Bartha, Geng Liu, George Coukos, Guilhem Richard, Chang Han, Han Si, Inka Zörnig, Ioannis Xénarios, Ion Măndoiu, Irsan Kooi, James Conway, Jan H. Kessler, Jason Greenbaum, Jason Perera, Jason Harris, Jasreet Hundal, Jennifer Shelton, Jianmin Wang, Jiaqian Wang, Joel Greshock, Jonathon Blake, Joseph D. Szustakowski, Julia Kodysh, Juliet Forman, Lei Wei, Leo J. Lee, Lorenzo F. Fanchi, Maarten Slagter, Maren Lang, Markus S. Mueller, Martin Löwer, Mathias Vormehr, Maxim N. Artyomov, Michael Kuziora, Michael F. Princiotta, Michal Bassani‐Sternberg, Mignonette H. Macabali, Milica Kojicic, Naibo Yang, Nevena Ilic Raicevic, Nicolas Guex, Nicolas Robine, Niels Halama, Nikola Skundric, Ognjen Milićević, Pascal Gellert, Patrick Jongeneel, Pornpimol Charoentong, Pramod K. Srivastava and 45 more - Cell 2020 cited by 550

  11. Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors

    Authors: , , , , , , , , , - Nature Medicine 2014 cited by 1,031

  12. PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Grégory Verdeil, Lana E. Kandalaft, Julien Dagher, Jesús Corría-Osorio, Marie‐Agnès Doucey, Ping‐Chih Ho, Alexandre Harari, Nicola Vannini, Jan P. Böttcher, Denarda Dangaj Laniti, George Coukos - Nature 2024 cited by 197

  13. Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stefan Zimmermann, Christine Sempoux, Urania Dafni, Alexandre Harari, Lana E. Kandalaft, Santiago J. Carmona, Denarda Dangaj Laniti, Melita Irving, George Coukos - Cancer Discovery 2021 cited by 423

  14. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Steven A. Narod, Brad H. Nelson, Kenneth P. Nephew, Paul D.P. Pharoah, Daniel J. Powell, Pilar Ramos, Iris L. Romero, Clare L. Scott, Anil K. Sood, Euan A. Stronach, Frances R. Balkwill - Nature reviews. Cancer 2015 cited by 1,425

  15. High-throughput automated organoid culture via stem-cell aggregation in microcavity arrays

    Authors: , , , , , , , , , , - Nature Biomedical Engineering 2020 cited by 388

  16. Radiotherapy combination opportunities leveraging immunity for the next oncology practice

    Authors: , , - CA A Cancer Journal for Clinicians 2016 cited by 516

  17. Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2018 cited by 441

  18. Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Science Advances 2021 cited by 320

  19. Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function

    Authors: , , , , , , - Frontiers in Immunology 2019 cited by 427

  20. Identification of tumor antigens with immunopeptidomics

    Authors: , , - Nature Biotechnology 2021 cited by 227

  21. Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Periklis Foukas, Daniel J. Powell, Sylvie Rusakiewicz, Marie‐Agnès Doucey, Denarda Dangaj Laniti, George Coukos - Cancer Cell 2021 cited by 194

  22. Immunobiology of high-grade serous ovarian cancer: lessons for clinical translation

    Authors: , , - Nature reviews. Cancer 2022 cited by 184

  23. Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis

    Authors: , , , , , , , , , , , , , , , , , - Annals of Oncology 2019 cited by 253

  24. Modulation of the antitumor immune response by complement

    Authors: , , , , , , , - Nature Immunology 2008 cited by 772